Martek Biosciences completes the acquisition of Amerifit Brands from Charterhouse Group

Martek Biosciences Corporation (Nasdaq: MATK) announced today that it has completed the purchase of Amerifit Brands, Inc. from Charterhouse Group, Inc. in an all-cash transaction valued at approximately $200 million. The acquisition was previously announced January 21, 2010.

Amerifit Brands develops, markets and distributes branded consumer health and wellness products focused on women's and digestive health benefits. Amerifit holds leading brand positions in all of its key product categories, and its products are sold in most major mass, club, drug, grocery and specialty stores. Amerifit's key products include: Culturelle®, a leading probiotic supplement; AZO®, the leading OTC brand addressing symptom relief, detection and prevention of urinary tract infections; and ESTROVEN®, the leading all-natural nutritional supplement brand addressing the symptoms of menopause.


Martek Biosciences Corporation


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.